Brett P. Monia, Chief Executive Officer at IONIS PHARMACEUTICALS INC (IONS), sold 85,637 shares at $78.41 ($6.8M) on 2026-06-24, disclosed to the SEC on 2026-06-26.
Scheduled sale ($6.8M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.41 | 14,565 | $1.1M | 16.7% |
| 2 | $78.49 | 21,072 | $1.7M | 24.2% |
| 3 | $80.59 | 50,000 | $4.0M | 59.0% |
| Total | $79.70 avg | 85,637 | $6.8M | 100% |
| Filing → |
| IONS | SELL | 2026-02-10 | $2.5M | — | Filing → |
| IONS | SELL | 2026-02-02 | $5.2M | — | Filing → |
| IONS | SELL | 2026-01-20 | $3.3M | — | Filing → |